Get our most recent news on nutraceuticals and vitamin C in India, CBD legislation in Australia, India and the Philippines, and Promisia's continued fight against government prosecution regarding its controversial arthritis supplement.
Here's a recap of our 10 most read nutrition stories in February, featuring Blackmores' financials, regulatory news from China, new innovations from Japan, and emerging research from New Zealand and India.
Read about China's continuing '100-day operation', closer inspection of infant formula, and the latest business developments in the country's supplement and health food market in our latest look at China.
New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
Here's a recap of our 10 most read nutrition stories in January, featuring regulatory updates from China and Australia, Nestlé's moves in the A2 milk market, the top APAC supplement trends to watch this year, and more.
Almost 60% of complementary healthcare practitioners in Australia think recent reforms by the Therapeutic Good Administration (TGA) have had an adverse impact on the industry, according to the regulator's own stakeholder survey.
From revamped regulations in New Zealand and India to controversy surrounding infant formula brands in APAC and a supplement firm in China, this month's regulatory review covers the latest news on ingredient, advertising and manufacturing laws in...
The announcement of New Zealand’s new Therapeutics Products Bill has brought with it hopes that new legislation may finally follow for natural products, with officials noting they are 'considering options' for separate regulations.